| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/14/2005 | CN1218715C Bone-setting silky fowl ointment for treating osteological diseases and its preparation and application |
| 09/14/2005 | CN1218697C Pharmaceutical composition for treating or improving arthritis and diet extender |
| 09/14/2005 | CN1218665C Defattedfrog spawn powder food for women |
| 09/13/2005 | US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl] |
| 09/13/2005 | US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis |
| 09/13/2005 | US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents |
| 09/13/2005 | US6943155 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 09/13/2005 | CA2371587C Piperidine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2371583C Piperazine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2279276C Arylsulfonylamino hydroxamic acid derivatives |
| 09/09/2005 | WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same |
| 09/09/2005 | WO2005082941A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | WO2005082905A1 Bicyclic heterocyclic compound |
| 09/09/2005 | WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082865A1 Fused bicyclic pyrimidine derivative |
| 09/09/2005 | WO2005082847A1 Bicyclo derivative |
| 09/09/2005 | WO2005082391A1 AGONIST TO HUMAN β3 ADRENALINE RECEPTOR |
| 09/09/2005 | WO2005011725A3 Anti-angiogenetic agent and its use, in particular in cancer treatment |
| 09/09/2005 | WO2003057854A3 Novel proteins and nucleic acids encoding same |
| 09/09/2005 | CA2846382A1 Iron based compounds for elastogenesis and connective tissue treatment |
| 09/09/2005 | CA2575416A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2557359A1 Semicarbazide derivatives as kinase inhibitors |
| 09/09/2005 | CA2556931A1 Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 for the prophylaxis of bone diseases |
| 09/09/2005 | CA2556914A1 Amines and amides for the treatment of diseases |
| 09/09/2005 | CA2556889A1 Dibenzo chromene derivatives and their use as er.beta. selective ligands |
| 09/09/2005 | CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins |
| 09/09/2005 | CA2555720A1 Isoquinoline derivatives |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 09/08/2005 | US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1570845A1 Remedy |
| 09/07/2005 | EP1569939A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 09/07/2005 | EP1569937A2 C-6 modified indazolylpyrrolotriazines |
| 09/07/2005 | EP1569928A1 Therapeutic compounds and methods |
| 09/07/2005 | EP1569924A2 Nf-kb inhibitors |
| 09/07/2005 | EP1569892A2 Calcilytic compounds |
| 09/07/2005 | EP1569676A2 Calcitonin drug-oligomer conjugates, and uses thereof |
| 09/07/2005 | EP1569672A1 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 09/07/2005 | EP1569632A1 Composition for the treatment of pain, especially for the treatment of articular pain |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1328519B1 Orally active salts with tyrosine kinase activity |
| 09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 09/07/2005 | EP1282621B1 Vitronectin receptor antagonists |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 09/07/2005 | EP0917537B1 Novel parathyroid hormone-related peptide analogs |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665811A Carbamate-substituted pyrazolopyridines |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665807A Novel physiolgically active substances |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665791A Quinazoline derivatives |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665554A Compounds and method for coating surfaces in a haemocompatible manner |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665525A Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1663599A Improved plaster for treating rheumatic and rheumatoid diseases and preparation method thereof |
| 09/07/2005 | CN1663595A Tendon-extending bone-penetrating spray of and its preparing method |
| 09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
| 09/07/2005 | CN1663587A Externally applied ointment |
| 09/07/2005 | CN1663583A Externally applied medicine for treating acute soft tissue injury |
| 09/07/2005 | CN1663580A Pain-relieving plaster for rheumatism and its preparation |
| 09/07/2005 | CN1663579A Pain-relieving bolus for rheumatism and its preparation |
| 09/07/2005 | CN1663577A Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
| 09/07/2005 | CN1663576A Chinese medicinal composition for treating bone fracture and soft tissue contusion |